See more : Sinnar Bidi Udyog Limited (SINNAR.BO) Income Statement Analysis – Financial Results
Complete financial analysis of COSMOS Pharmaceutical Corporation (CSMYF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of COSMOS Pharmaceutical Corporation, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Learning Technologies Group plc (LTG.L) Income Statement Analysis – Financial Results
- ispace, inc. (9348.T) Income Statement Analysis – Financial Results
- Otonomy, Inc. (OTIC) Income Statement Analysis – Financial Results
- SAMICK MUSICAL INSTRUMENT Co., Ltd (002450.KS) Income Statement Analysis – Financial Results
- Alpha Astika Akinita S.A. (ASTAK.AT) Income Statement Analysis – Financial Results
COSMOS Pharmaceutical Corporation (CSMYF)
About COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. As of May 31, 2022, the company operated 1,244 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was incorporated in 1983 and is headquartered in Fukuoka, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 964.99B | 827.70B | 755.41B | 726.42B | 684.40B | 611.14B | 558.00B | 502.73B | 447.27B | 408.47B | 371.83B | 329.31B | 279.02B | 237.17B | 205.39B | 177.76B | 148.24B | 125.85B | 105.05B | 78.65B |
| Cost of Revenue | 776.68B | 658.98B | 603.97B | 581.31B | 549.42B | 489.35B | 447.68B | 402.69B | 360.42B | 330.39B | 301.27B | 267.53B | 226.04B | 191.67B | 165.32B | 141.74B | 115.55B | 97.49B | 81.76B | 60.94B |
| Gross Profit | 188.31B | 168.72B | 151.45B | 145.11B | 134.98B | 121.78B | 110.32B | 100.04B | 86.85B | 78.08B | 70.56B | 61.79B | 52.99B | 45.50B | 40.06B | 36.02B | 32.70B | 28.36B | 23.29B | 17.71B |
| Gross Profit Ratio | 19.51% | 20.38% | 20.05% | 19.98% | 19.72% | 19.93% | 19.77% | 19.90% | 19.42% | 19.11% | 18.98% | 18.76% | 18.99% | 19.19% | 19.51% | 20.26% | 22.06% | 22.53% | 22.17% | 22.52% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 116.00M | 128.00M | 127.00M | 129.00M | 127.00M | 128.00M | 129.00M | 118.00M | 117.00M | 116.00M | 119.00M | 127.00M | 0.00 | 0.00 | 0.00 | 0.00 | 3.98B | 4.60B | 3.88B | 3.11B |
| Selling & Marketing | 1.81B | 1.65B | 1.63B | 2.78B | 4.27B | 3.77B | 1.84B | 1.82B | 1.69B | 1.78B | 1.65B | 1.30B | 0.00 | 0.00 | 0.00 | 0.00 | 1.22B | 929.00M | 896.00M | 764.00M |
| SG&A | 1.93B | 122.81B | 107.76B | 99.16B | 93.35B | 85.05B | 76.68B | 68.10B | 59.44B | 54.10B | 48.52B | 42.09B | 0.00 | 0.00 | 0.00 | 0.00 | 5.20B | 5.53B | 4.78B | 3.87B |
| Other Expenses | 154.88B | 2.96B | 3.07B | 2.74B | 2.55B | 2.52B | 2.52B | 2.37B | 2.04B | 1.62B | 1.44B | 1.21B | 1.16B | 1.04B | 1.10B | 802.00M | 688.00M | 652.00M | 476.00M | 291.00M |
| Operating Expenses | 156.81B | 138.59B | 121.65B | 111.96B | 105.89B | 97.01B | 87.57B | 77.81B | 68.21B | 60.99B | 53.85B | 46.26B | 39.66B | 35.46B | 32.32B | 30.58B | 27.89B | 24.59B | 19.88B | 15.46B |
| Cost & Expenses | 933.49B | 797.57B | 725.62B | 693.28B | 655.31B | 586.36B | 535.25B | 480.49B | 428.63B | 391.38B | 355.12B | 313.78B | 265.69B | 227.13B | 197.64B | 172.32B | 143.44B | 122.08B | 101.64B | 76.39B |
| Interest Income | 44.00M | 47.00M | 52.00M | 57.00M | 65.00M | 72.00M | 78.00M | 85.00M | 91.00M | 93.00M | 97.00M | 102.00M | 109.00M | 110.00M | 103.00M | 108.00M | 90.00M | 62.00M | 44.00M | 33.00M |
| Interest Expense | 99.00M | 51.00M | 52.00M | 60.00M | 69.00M | 77.00M | 88.00M | 98.00M | 91.00M | 55.00M | 50.00M | 57.00M | 81.00M | 116.00M | 141.00M | 130.00M | 120.00M | 101.00M | 88.00M | 116.00M |
| Depreciation & Amortization | 19.92B | 17.37B | 15.11B | 13.79B | 13.56B | 12.96B | 11.89B | 10.71B | 9.59B | 7.34B | 5.60B | 4.25B | 3.10B | 2.36B | 1.86B | 1.42B | 1.03B | 844.00M | 634.00M | 418.00M |
| EBITDA | 53.74B | 47.50B | 44.91B | 46.93B | 42.66B | 37.73B | 34.64B | 32.95B | 28.24B | 24.42B | 22.31B | 20.96B | 17.58B | 13.05B | 10.75B | 6.88B | 6.61B | 5.27B | 4.44B | 2.94B |
| EBITDA Ratio | 5.57% | 6.10% | 6.36% | 6.85% | 6.61% | 6.60% | 6.67% | 7.04% | 6.79% | 6.47% | 6.41% | 6.40% | 6.34% | 5.71% | 5.26% | 4.37% | 4.46% | 4.23% | 4.34% | 3.81% |
| Operating Income | 31.50B | 30.13B | 29.80B | 33.15B | 29.09B | 24.78B | 22.75B | 22.24B | 18.65B | 17.08B | 16.71B | 15.53B | 14.60B | 11.19B | 8.94B | 6.35B | 5.59B | 4.48B | 3.93B | 2.58B |
| Operating Income Ratio | 3.26% | 3.64% | 3.94% | 4.56% | 4.25% | 4.05% | 4.08% | 4.42% | 4.17% | 4.18% | 4.49% | 4.72% | 5.23% | 4.72% | 4.35% | 3.57% | 3.77% | 3.56% | 3.74% | 3.28% |
| Total Other Income/Expenses | 2.22B | 2.64B | 3.25B | 5.45B | 1.31B | 2.36B | 2.42B | 3.50B | 1.85B | 2.34B | 1.71B | 1.12B | -199.00M | 529.00M | -186.00M | -113.00M | -677.00M | -156.00M | -209.00M | -180.00M |
| Income Before Tax | 33.72B | 32.77B | 33.05B | 38.60B | 30.40B | 27.14B | 25.17B | 25.74B | 20.50B | 19.42B | 18.42B | 16.65B | 14.40B | 10.57B | 8.76B | 5.33B | 4.13B | 4.32B | 3.72B | 2.40B |
| Income Before Tax Ratio | 3.49% | 3.96% | 4.37% | 5.31% | 4.44% | 4.44% | 4.51% | 5.12% | 4.58% | 4.75% | 4.95% | 5.06% | 5.16% | 4.46% | 4.26% | 3.00% | 2.79% | 3.43% | 3.54% | 3.05% |
| Income Tax Expense | 9.27B | 8.98B | 9.89B | 11.44B | 8.97B | 7.95B | 7.53B | 7.52B | 8.06B | 7.73B | 7.82B | 7.26B | 6.66B | 4.83B | 4.04B | 2.48B | 1.96B | 2.02B | 1.78B | 1.14B |
| Net Income | 24.45B | 23.80B | 23.16B | 27.16B | 21.44B | 19.19B | 17.63B | 18.22B | 12.44B | 11.69B | 10.60B | 9.40B | 7.74B | 5.74B | 4.71B | 2.84B | 2.17B | 2.30B | 1.94B | 1.26B |
| Net Income Ratio | 2.53% | 2.88% | 3.07% | 3.74% | 3.13% | 3.14% | 3.16% | 3.62% | 2.78% | 2.86% | 2.85% | 2.85% | 2.77% | 2.42% | 2.29% | 1.60% | 1.47% | 1.83% | 1.85% | 1.60% |
| EPS | 308.61 | 600.95 | 584.74 | 685.77 | 541.30 | 484.48 | 445.29 | 459.98 | 314.02 | 295.31 | 267.68 | 237.28 | 195.38 | 144.87 | 118.99 | 71.74 | 54.47 | 57.47 | 51.02 | 75.95 |
| EPS Diluted | 308.61 | 600.95 | 584.74 | 685.77 | 541.30 | 484.48 | 445.29 | 459.98 | 314.02 | 295.31 | 267.68 | 237.28 | 195.38 | 144.87 | 118.99 | 71.74 | 54.47 | 57.47 | 51.02 | 75.95 |
| Weighted Avg Shares Out | 79.24M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.89M | 40.00M | 38.11M | 16.58M |
| Weighted Avg Shares Out (Dil) | 79.24M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | 39.89M | 40.00M | 38.11M | 16.58M |
No news found for: CSMYF
Source: https://incomestatements.info
Category: Stock Reports